Literature DB >> 28063089

The Natural Course of Atopic Dermatitis and the Association with Asthma.

Min Qiao1, Deqi Xiao2, Li Qian3, Jian'ou Qiao4,5.   

Abstract

In this paper, we aimed to explore the potential mechanism underlying atopic dermatitis (AD) and its association with asthma. The BALB/c mice were randomly assigned to three groups, including the vehicle control (VD) group, the AD group, and the treatment (TR) group. The AD mice model was successfully constructed in the AD and TR group. The dermatitis severity scores and skin lesions were significantly increased in AD mice after DNCB application. Airway responsiveness in the AD group was significantly higher than in the TR group. The number of inflammatory cells was increased in skin lesions and bronchoalveolar lavage fluid (BALF) of AD mice. The levels of IL-4, IL-5, IFN-γ, and OVA-IgE in BALF supernatants of mice in the AD group were higher than those in the VC group. All the changes in AD mice were decreased by tacrolimus. These results indicate that AD may be a significant risk factor for atopic asthma development.

Entities:  

Keywords:  airway inflammation; airway responsiveness; asthma; atopic dermatitis; tacrolimus

Mesh:

Substances:

Year:  2017        PMID: 28063089     DOI: 10.1007/s10753-016-0501-5

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis.

Authors:  S Reitamo
Journal:  J Allergy Clin Immunol       Date:  2001-03       Impact factor: 10.793

Review 2.  Eosinophilic bronchitis: clinical manifestations and implications for treatment.

Authors:  P G Gibson; M Fujimura; A Niimi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

Review 3.  Genes, environments, development and asthma: a reappraisal.

Authors:  F D Martinez
Journal:  Eur Respir J       Date:  2007-01       Impact factor: 16.671

4.  Natural course of sensitization to food and inhalant allergens during the first 6 years of life.

Authors:  M Kulig; R Bergmann; U Klettke; V Wahn; U Tacke; U Wahn
Journal:  J Allergy Clin Immunol       Date:  1999-06       Impact factor: 10.793

5.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

6.  Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis.

Authors:  M Aleksza; A Lukács; P Antal-Szalmás; J Hunyadi; A Szegedi
Journal:  Br J Dermatol       Date:  2002-12       Impact factor: 9.302

7.  An obligate role for T-cell receptor alphabeta+ T cells but not T-cell receptor gammadelta+ T cells, B cells, or CD40/CD40L interactions in a mouse model of atopic dermatitis.

Authors:  A L Woodward; J M Spergel; H Alenius; E Mizoguchi; A K Bhan; E Castigli; S R Brodeur; H C Oettgen; R S Geha
Journal:  J Allergy Clin Immunol       Date:  2001-02       Impact factor: 10.793

8.  Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling.

Authors:  Wataru Ito; Arihiko Kanehiro; Kunio Matsumoto; Atsushi Hirano; Katsuichiro Ono; Hiromi Maruyama; Mikio Kataoka; Toshikazu Nakamura; Erwin W Gelfand; Mitsune Tanimoto
Journal:  Am J Respir Cell Mol Biol       Date:  2004-12-30       Impact factor: 6.914

9.  The natural course of atopic dermatitis from birth to age 7 years and the association with asthma.

Authors:  Sabina Illi; Erika von Mutius; Susanne Lau; Renate Nickel; Christoph Grüber; Bodo Niggemann; Ulrich Wahn
Journal:  J Allergy Clin Immunol       Date:  2004-05       Impact factor: 10.793

Review 10.  Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases.

Authors:  D Y Leung
Journal:  J Allergy Clin Immunol       Date:  1995-09       Impact factor: 10.793

View more
  2 in total

1.  The STAT6 inhibitor AS1517499 reduces the risk of asthma in mice with 2,4-dinitrochlorobenzene-induced atopic dermatitis by blocking the STAT6 signaling pathway.

Authors:  Xueying Li; Zhaoqing Han; Feng Wang; Jianou Qiao
Journal:  Allergy Asthma Clin Immunol       Date:  2022-02-17       Impact factor: 3.406

2.  Identification of biomarkers in common chronic lung diseases by co-expression networks and drug-target interactions analysis.

Authors:  Mazaher Maghsoudloo; Sadegh Azimzadeh Jamalkandi; Ali Najafi; Ali Masoudi-Nejad
Journal:  Mol Med       Date:  2020-01-17       Impact factor: 6.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.